Descriptor English: | Adjuvants, Vaccine | ||||||
Descriptor Spanish: |
Adyuvantes de Vacunas
| ||||||
Descriptor Portuguese: | Adjuvantes de Vacinas | ||||||
Descriptor French: | Adjuvants vaccinaux | ||||||
Entry term(s): |
Vaccine Adjuvant Vaccine Adjuvants |
||||||
Tree number(s): |
D26.650.064.500 D27.505.696.477.067.500 D27.720.744.064.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000089582 | ||||||
Scope note: | Substances consisting of different components, e.g. aluminum salts, EMULSIONS such as MF59 and AS03, Toll-like receptor (TLR) agonist or combinations of IMMUNOPOTENTIATORS (QS-21 and MPL in AS01), that helps increase the magnitude of an ADAPTIVE IMMUNE RESPONSE to a VACCINE. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Previous Indexing: |
Administration, Cutaneous (1975-2021) |
||||||
Public MeSH Note: | 2022 |
||||||
History Note: | 2022 |
||||||
DeCS ID: | 59729 | ||||||
Unique ID: | D000089582 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2022/01/01 | ||||||
Date of Entry: | 2021/07/09 | ||||||
Revision Date: | 2021/07/01 |
-
-
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations -
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses -
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
Adjuvants, Vaccine
- Preferred
Concept UI |
M000744470 |
Scope note | Substances consisting of different components, e.g. aluminum salts, EMULSIONS such as MF59 and AS03, Toll-like receptor (TLR) agonist or combinations of IMMUNOPOTENTIATORS (QS-21 and MPL in AS01), that helps increase the magnitude of an ADAPTIVE IMMUNE RESPONSE to a VACCINE. |
Preferred term | Adjuvants, Vaccine |
Entry term(s) |
Vaccine Adjuvant Vaccine Adjuvants |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey